Bringing the fundamentals into focus…
Back to Nektar Therapeutics
How Nektar Therapeutics stacks up
NKTR · against 444 other Healthcare companies of similar size
Profitability
12/ 100
Near the bottom of its peers.
Ranked #403 of 445 · scores higher than 9% of peers
Bars: peers in each 10-point band of the profitability score45 peers with a profitability score of 10–19, including NKTR · Click a bar to see the companies
Why profitability scores 12?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 90% of peers. Operating margin: -236.8% vs peer median 7.1%
- a lower return on invested capital: weaker than 88% of peers. Return on invested capital: -50.1% vs peer median 4.7%
- a lower return on assets: weaker than 76% of peers. Return on assets: -12.5% vs peer median 1.7%
Metric by metric
Position: dot = NKTR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NKTR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 421 reported | -50.1% | 5.2% | 11% | 33% | |
| Operating marginHigher is better · 418 reported | -236.8% | 7.0% | 7% | 33% | |
| Return on assetsHigher is better · 432 reported | -12.5% | 1.8% | 21% | 33% | |
| Return on equityHigher is better · 415 reported | -35.8% | 3.1% | 20% | Context only | |
| Gross marginHigher is better · 464 reported | 100.0% | 47.3% | 97% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around NKTR| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 3 | 914M USD | 99 | 81 | |
| 396 | 1.2B CHF (≈$1.3B) | 13 | 28 | |
| 396 | 1.4B USD | 13 | 39 | |
| 396 | 1.7B USD | 13 | 21 | |
| 396 | 673M USD | 13 | 35 | |
| 403 | 1.3B USD | 12 | 27 | |
| 403 | 1.3B USD | 12 | 33 | |
| 403 | 2.2B USD | 12 | 35 | |
| 406 | 660M USD | 11 | 43 | |
| 406 | 1.3B USD | 11 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score